Xavier Bossuyt

Papers

Total Citations

H-Index

About

Xavier Bossuyt is a leading figure in clinical immunology and autoimmunity, renowned for his pioneering work in the standardization and automation of antinuclear antibody (ANA) detection—a cornerstone of diagnosing systemic autoimmune rheumatic diseases. His major contributions include advancing the reliability of indirect immunofluorescence (IIF) analysis, the gold-standard method for ANA screening, by systematically evaluating variations in automated systems. His highly cited 2018 study, "Variation in antinuclear antibody detection by automated indirect immunofluorescence analysis" (30 citations), critically assessed inter-assay and inter-laboratory variability, providing essential data to improve diagnostic accuracy and reproducibility. This work has had a profound impact on clinical laboratories worldwide, helping to reduce false positives and enhance patient care. Bossuyt’s research also extends to the characterization of autoantibody profiles and their clinical associations, solidifying his reputation as a key contributor to the field. His findings are frequently referenced in guidelines and have shaped best practices in autoimmune serology. For students and researchers, Bossuyt exemplifies how rigorous method validation can transform routine diagnostics into more precise tools for patient management.